How Often Should You Take Enclomiphene?

Every clinical trial of enclomiphene citrate to date has used once-daily dosing, and that is the frequency most prescribers follow. The drug was studied at 6.25 mg, 12.5 mg, and 25 mg taken every morning, with participants instructed to take their capsule between 7:00 and 10:00 a.m. There is no published evidence supporting every-other-day, twice-daily, or cyclical schedules, even though those regimens circulate widely in online forums. The daily protocol is grounded in how the drug behaves in the body and what outcomes it produces over weeks and months.

What the Clinical Trials Actually Tested

The most detailed pharmacokinetic and pharmacodynamic data come from a randomized trial that assigned 48 men with secondary hypogonadism to one of four arms: enclomiphene at 6.25 mg daily, 12.5 mg daily, 25 mg daily, or transdermal testosterone gel. After six weeks of continuous daily dosing, the 25 mg group reached a mean total testosterone of about 604 ng/dL, compared to roughly 500 ng/dL in the testosterone gel group. All three enclomiphene dose groups saw statistically significant increases in total testosterone from baseline, including the lowest 6.25 mg dose.¹ Every one of those arms used once-daily dosing. No arm tested alternate-day schedules, pulsed cycles, or loading phases.

A separate study looking at obese hypogonadal men over 16 weeks also used daily oral enclomiphene and found sustained increases in both testosterone and gonadotropins throughout that period.² Retrospective clinical data examining enclomiphene over a minimum of three months likewise assumed daily use.³ The consistent thread across all published work is one pill, once a day, every day.

Why Morning Dosing

In the pharmacokinetic trial, subjects were specifically instructed to take their capsule between 7:00 and 10:00 a.m.¹ That window was chosen to align with the body’s natural testosterone rhythm. Healthy men produce most of their testosterone in the early morning hours, with levels peaking around wake-up and declining through the afternoon and evening. By taking enclomiphene in the morning, the drug’s stimulatory signal to the pituitary gland arrives when the hypothalamic-pituitary-gonadal axis is already primed for its daily surge.

Does taking it at noon or in the evening ruin the effect? No trial has tested that head to head, so the honest answer is that we do not know for certain. What we do know is that the favorable outcomes in every study came from morning administration, and deviating from the studied protocol means you are in uncharted territory. If you occasionally take your dose a few hours late, the drug still reaches your bloodstream and still blocks estrogen receptors at the pituitary. But consistently dosing at night would shift when the LH signal peaks relative to the body’s own circadian cues, and no one has measured whether that matters.

How Long It Takes to Work

Enclomiphene does not produce overnight results. In the six-week trial, testosterone levels were measured on day 42, and by that point, the 25 mg group had reached the mid-normal range.¹ LH levels rose in parallel with testosterone across the enclomiphene groups, confirming that the drug was working through the body’s own hormone-production pathway rather than bypassing it.¹ That built-in relay, where the drug nudges the pituitary, the pituitary signals the testes, and the testes gradually increase output, means the timeline is measured in weeks, not days.

Longer studies show that the effect continues building and stabilizing over months. In a trial comparing enclomiphene to testosterone gel over six months, sperm counts rose steadily in the enclomiphene group, with seven out of seven men showing elevated counts at three months and six out of six at six months.⁴ The 16-week study in obese men found that gonadotropin increases persisted throughout.² The practical takeaway is that consistent daily use for at least six weeks is the minimum before judging whether the drug is doing its job, and three months gives a fuller picture, especially for fertility endpoints.

The Case Against Cycling or Skipping Days

A common question in men’s health forums is whether you can take enclomiphene every other day, or do a few weeks on and a few weeks off. This idea usually comes from two places: wanting to save money by stretching a prescription, or borrowing the “cycling” concept from anabolic steroid use and applying it to a drug that works very differently.

Enclomiphene works by blocking estrogen receptors in the pituitary, which removes the negative-feedback signal that normally tells the brain “we have enough testosterone, stop making LH.” As long as the drug is present at the receptor, LH production stays elevated and testosterone follows. Remove the drug, and the feedback loop re-engages. The pituitary sees circulating estrogen (which rises alongside testosterone), reads it as a stop signal, and dials LH back down. At the 25 mg daily dose, men in the trial saw LH rise from about 5.3 to nearly 12 mIU/mL.⁵ That elevation depends on consistent receptor blockade.

The half-life of enclomiphene is relatively short compared to its isomer zuclomiphene, which is the other half of the mixed drug clomiphene (Clomid). Zuclomiphene can linger in the body for weeks, which is partly why traditional clomiphene has a reputation for estrogenic side effects that build up over time. Enclomiphene clears faster, which is a feature when it comes to side effects but a liability if you skip doses. With less drug hanging around between doses, every-other-day dosing would create troughs deep enough that estrogen feedback partially resumes, producing a seesaw rather than a steady signal.

No trial has tested alternate-day or cyclical enclomiphene, so anyone following such a protocol is experimenting on themselves without data. The consistent daily dosing in every published study is not an arbitrary choice; it reflects the pharmacology.

Dose Adjustments and Who Gets What

The three doses tested, 6.25 mg, 12.5 mg, and 25 mg, all raised testosterone, but the magnitude differed. The 25 mg group reached the highest mean testosterone and showed the most robust LH response.¹ In clinical practice, many prescribers start at 12.5 mg or 25 mg daily and adjust based on follow-up labs drawn at around six weeks. If testosterone overshoots or estradiol climbs higher than desired, the dose may be lowered. If the response is underwhelming, a higher dose can be tried before concluding that the drug is not working for that individual.

Body weight seems to matter. The 16-week study specifically enrolled obese hypogonadal men and found that daily enclomiphene still raised testosterone and preserved sperm counts in that population.² Higher body fat means more aromatase activity, the enzyme that converts testosterone to estradiol. A man with more body fat will produce more estradiol for a given testosterone level, which could partially blunt the effect of a lower enclomiphene dose. This is one reason some clinicians lean toward the 25 mg dose for heavier patients, though no trial has directly compared dose-by-weight strategies.

Fertility Preservation Is a Major Reason for Daily Use

One of the biggest advantages of enclomiphene over exogenous testosterone is its effect on sperm production. Testosterone replacement therapy, whether by injection, gel, or pellet, suppresses the pituitary signals that drive spermatogenesis. Many men on testosterone therapy see their sperm counts drop to near zero. Enclomiphene does the opposite: because it raises LH and FSH rather than suppressing them, it supports or even enhances sperm production while simultaneously raising testosterone.

In a head-to-head comparison with testosterone gel, enclomiphene elevated sperm counts in every man tested at three months and nearly every man at six months, with concentrations reaching 75 to 334 million per milliliter. The gel group, by contrast, failed to raise any man’s sperm count above 20 million per milliliter at three months.⁴ A retrospective study also found that both total motile sperm counts and motility improved in men taking enclomiphene, whereas clomiphene (the mixed isomer drug) improved only motility.³

This fertility benefit depends entirely on consistent daily dosing. FSH, the hormone that directly drives sperm cell maturation, needs to remain elevated over the full cycle of sperm development, which takes roughly 72 days. Intermittent dosing would allow FSH to dip, potentially disrupting spermatogenesis partway through. If preserving or improving fertility is one of your reasons for choosing enclomiphene, daily use is not optional; it is the mechanism by which the drug does its job.

Side Effects and How They Compare to Clomiphene

One reason enclomiphene generates interest over traditional clomiphene (Clomid) is its side-effect profile. Clomiphene is a roughly 60/40 mix of two mirror-image molecules: enclomiphene (the trans-isomer, which acts as an estrogen antagonist) and zuclomiphene (the cis-isomer, which has estrogenic effects and a much longer half-life). Zuclomiphene is thought to be responsible for many of the mood changes, visual disturbances, and estrogenic side effects that some men experience on Clomid.

A study comparing the two drugs directly found that side effects were reported by about 14% of patients taking enclomiphene versus 47% of those on clomiphene. Decreased libido occurred in roughly 9% on enclomiphene compared to a third on clomiphene. Mood changes showed up in about 9% of the clomiphene group and were absent in the enclomiphene group entirely.⁶ Regression analysis in that study confirmed substantially lower odds of any adverse event with enclomiphene.

The lower side-effect rate is worth noting in the context of dosing frequency because it means most men tolerate daily use well. With clomiphene, some clinicians prescribe every-other-day or three-times-weekly dosing partly to manage side effects caused by zuclomiphene accumulation. That rationale does not transfer to enclomiphene, which lacks the problematic isomer. Reducing the frequency to manage side effects you are unlikely to experience in the first place sacrifices efficacy for no clear gain.

An Effect Worth Monitoring Over Time

A recent study flagged a less-discussed consequence of long-term use: changes in insulin-like growth factor 1 (IGF-1). In a cohort of 20 men treated with clomiphene (the mixed drug), three-quarters showed a decrease in IGF-1 levels, and two patients dropped to levels more than two standard deviations below their age-matched average.⁷ IGF-1 is involved in muscle growth, bone density, and tissue repair, so a sustained decline could offset some of the benefits men are seeking from testosterone restoration.

This study used clomiphene rather than pure enclomiphene, so it is not certain the same effect occurs with enclomiphene alone. Estrogen receptor blockade at the pituitary could plausibly alter growth hormone dynamics regardless of which isomer does the blocking, but the estrogenic effects of zuclomiphene might contribute differently. The finding is preliminary and comes from a small cohort, but it is the kind of thing that argues for periodic lab work beyond just testosterone and estradiol. If you are taking enclomiphene daily for months or years, asking your prescriber to check IGF-1 at intervals is reasonable.

Anti-Doping Considerations

If you compete in any sport governed by the World Anti-Doping Agency, enclomiphene is prohibited at all times, both in and out of competition. Clomiphene and its isomers fall under Section 4.2 of the WADA Prohibited List, which covers anti-estrogenic substances used to enhance endogenous testosterone production.⁸ This applies whether you have a prescription or not and regardless of whether your use is daily or sporadic. A three-year analysis of anti-doping samples found clomiphene and its metabolites appearing routinely, indicating ongoing use among athletes despite the ban.

For competitive athletes prescribed enclomiphene for a legitimate medical condition, a Therapeutic Use Exemption is theoretically available but difficult to obtain for this class of drug. Most anti-doping authorities view testosterone-boosting agents with considerable skepticism even when prescribed. If you fall into this category, the dosing question is beside the point until the regulatory question is resolved.

What Happens When You Stop

Enclomiphene does not permanently reset the hypothalamic-pituitary-gonadal axis. When you stop taking it, the estrogen receptors in the pituitary are no longer blocked, negative feedback resumes, and LH gradually falls back toward its pre-treatment level. Testosterone follows. In men whose low testosterone stems from a reversible cause like obesity, weight loss during enclomiphene use might independently improve their hormonal environment enough that stopping the drug does not return them to their starting point. But in men with secondary hypogonadism from other causes, the underlying issue remains once the drug is withdrawn.

This is why daily dosing is generally open-ended rather than a fixed course. Enclomiphene is not like an antibiotic where you take it for ten days and the problem is solved. It is closer to a blood pressure medication: it works while you take it, and the condition it manages returns when you do not. Some men use it for a defined period, such as while trying to conceive, then transition to testosterone replacement therapy once fertility is no longer a concern. Others stay on it indefinitely as their preferred form of testosterone support. Either approach assumes consistent daily use for the duration.